Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma announces initiation of the registrational Phase 3 ZUPREME program of petrelintide in people with overweight or obesity
Press release – No. 17 / 2026 Zealand Pharma announces initiation of the registrational Phase 3 ZUPREME program of petrelintide in people with overweight or obesity The Phase 3 initiation marks a defining step toward establishing…
Duke Street sells UK pharma distributor Kent Pharma to Phoenix Labs
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
Ascendis Pharma (NASDAQ: ASND) Severs Novo Nordisk Tie To Take Full Control Of TransCon Metabolic Pipeline
Ascendis Pharma (NASDAQ: ASND) has reclaimed exclusive rights to its TransCon technology-based products across metabolic and cardiovascular diseases following the termination of its collaboration with Novo Nordisk (NYSE: NVO). The move signals a…
Andra AP fonden Lowers Stock Holdings in Royalty Pharma PLC $RPRX
Andra AP fonden lowered its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 21.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned…
Pharmalittle: We're reading about pharma seeking to protect China deals, a Roche obesity drug, and more
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say “Every new day should be…
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Consensus Recommendation of 'Moderate Buy' from Brokerages
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) have been given an average recommendation of 'Moderate Buy' by the twenty-three ratings firms that are presently covering the firm, MarketBeat Ratings reports. One investment analyst…
Cybin Shareholders Weigh Helus Pharma Rebrand, Eight-Member Board
Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise Cybin NASDAQ: HELP, doing business as Helus Pharma, held its Annual General and Special Meeting of Shareholders, where shareholders were asked to consider resolutions related to…
Labcorp's Future Driven By Clinical Testing Demand, Despite Impact From Medicare Cuts (LH)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Cosmetics From Pakistan Breach Indian Market
CDSCO has warned consumers against using two unauthorised Pakistani whitening creams after finding excessive heavy metals and regulatory violations. India's CDSCO has issued a public health warning against Goree beauty cream and Chandni whitening…
European drugmakers say they are 'losing ground' to US and Chinese rivals
Some of Europe's biggest pharmaceutical companies have said the continent is “losing ground” to rivals including the US and China in developing new drugs and attracting investment. The chairs of nine companies, including Britain's…
Roche obesity shot reduced body weight by 15.5% in trial
Patients receiving the highest 24-milligram dose had a 2.65% reduction in HbA1c – a measure of blood sugar – and lost an average 15.5% of their body weight after 48 weeks with no plateau observed, Roche said. The data “look…
Equity Lifestyle Properties: Single-Family REIT Showing A Growth Case
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
AC Immune Reports Positive Safety & Immunogenicity at week-100 in Part 1 of VacSYn Phase 2 Trial of ACI-7104
All primary endpoints of the study were met, with ACI-7104 shown to be generally safe and well tolerated Strong immunogenicity demonstrated, with 100% response rate after three immunizations Clear antibody penetration into the cerebrospinal fluid…
Pfizer (PFE): A Quietly Outperforming High-Dividend Idea, Pipeline On Watch
Pfizer is upgraded to buy, supported by a low valuation, strong free cash flow, and a high 6.2% dividend yield. PFE delivered a Q2 double beat, raised full-year revenue guidance, and benefits from pipeline progress, though COVID-19 product sales…
Roivant Sciences Ltd. (ROIV) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Roivant Sciences Ltd. (ROIV) Bank of America Global Healthcare Conference 2026 September 22, 2026 8:20 AM EDT Richard Wagner - BofA Securities, Research Division BofA Securities, Research Division Good afternoon. Welcome back from lunch. To…
Receive a Daily briefing on Pharma Industry News
Get Started